-
Something wrong with this record ?
FungiScope™-Global Emerging Fungal Infection Registry
D. Seidel, LA. Durán Graeff, MJGT. Vehreschild, H. Wisplinghoff, M. Ziegler, JJ. Vehreschild, B. Liss, A. Hamprecht, P. Köhler, Z. Racil, N. Klimko, DC. Sheppard, R. Herbrecht, A. Chowdhary, OA. Cornely, . FungiScope Group,
Language English Country Germany
Document type Journal Article
PubMed
28730644
DOI
10.1111/myc.12631
Knihovny.cz E-resources
- MeSH
- Global Health * MeSH
- Immunocompromised Host MeSH
- Invasive Fungal Infections MeSH
- Humans MeSH
- Mycoses * MeSH
- Communicable Diseases, Emerging * MeSH
- Registries * standards MeSH
- Quality Control MeSH
- Rare Diseases * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Rare invasive fungal diseases (IFD) are challenging for the treating physicians because of their unspecific clinical presentation, as well as the lack of standardised diagnostic and effective treatment strategies. Late onset of treatment and inappropriate medication is associated with high mortality, thus, urging the need for a better understanding of these diseases. The purpose of FungiScope™is to continuously collect clinical information and specimens to improve the knowledge on epidemiology and eventually improve patient management of these orphan diseases. FungiScope™was founded in 2003, and today, collaborators from 66 countries support the registry. So far, clinical data of 794 cases have been entered using a web-based approach. Within the growing network of experts, new collaborations developed, leading to several publications of comprehensive analyses of patient subgroups identified from the registry. Data extracted from FungiScope™have also been used as the sole control group for the approval of a new antifungal drug. Due to the rarity of these diseases, a global registry is an appropriate method of pooling the scarce and scattered information. Joining efforts across medical specialities and geographical borders is key for researching rare IFD. Here, we describe the structure and management of the FungiScope™registry.
Department 1 of Internal Medicine University Hospital Cologne Cologne Germany
Department of Medical Mycology Vallabhbhai Patel Chest Institute University of Delhi Delhi India
HELIOS Klinik Wuppertal Barmen Wuppertal Germany
Institute for Medical Microbiology Immunology and Hygiene University of Cologne Cologne Germany
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18010410
- 003
- CZ-PrNML
- 005
- 20180417152210.0
- 007
- ta
- 008
- 180404s2017 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/myc.12631 $2 doi
- 035 __
- $a (PubMed)28730644
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Seidel, Danila $u Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.
- 245 10
- $a FungiScope™-Global Emerging Fungal Infection Registry / $c D. Seidel, LA. Durán Graeff, MJGT. Vehreschild, H. Wisplinghoff, M. Ziegler, JJ. Vehreschild, B. Liss, A. Hamprecht, P. Köhler, Z. Racil, N. Klimko, DC. Sheppard, R. Herbrecht, A. Chowdhary, OA. Cornely, . FungiScope Group,
- 520 9_
- $a Rare invasive fungal diseases (IFD) are challenging for the treating physicians because of their unspecific clinical presentation, as well as the lack of standardised diagnostic and effective treatment strategies. Late onset of treatment and inappropriate medication is associated with high mortality, thus, urging the need for a better understanding of these diseases. The purpose of FungiScope™is to continuously collect clinical information and specimens to improve the knowledge on epidemiology and eventually improve patient management of these orphan diseases. FungiScope™was founded in 2003, and today, collaborators from 66 countries support the registry. So far, clinical data of 794 cases have been entered using a web-based approach. Within the growing network of experts, new collaborations developed, leading to several publications of comprehensive analyses of patient subgroups identified from the registry. Data extracted from FungiScope™have also been used as the sole control group for the approval of a new antifungal drug. Due to the rarity of these diseases, a global registry is an appropriate method of pooling the scarce and scattered information. Joining efforts across medical specialities and geographical borders is key for researching rare IFD. Here, we describe the structure and management of the FungiScope™registry.
- 650 12
- $a objevující se infekční nemoci $7 D021821
- 650 12
- $a celosvětové zdraví $7 D014943
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunokompromitovaný pacient $7 D016867
- 650 _2
- $a invazivní mykotické infekce $7 D000072742
- 650 12
- $a mykózy $7 D009181
- 650 _2
- $a řízení kvality $7 D011786
- 650 12
- $a vzácné nemoci $7 D035583
- 650 12
- $a registrace $x normy $7 D012042
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Durán Graeff, Luisa A $u Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.
- 700 1_
- $a Vehreschild, Maria J G T $u Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany. Medical Faculty, Center for Integrated Oncology CIO Cologne/Bonn, University of Cologne, Cologne, Germany. German Centre for Infection Research (DZIF), partner site Bonn-Cologne, Cologne, Germany.
- 700 1_
- $a Wisplinghoff, Hilmar $u Wisplinghoff Laboratories, Cologne, Germany. Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne, Germany. Institute for Medical Microbiology and Virology, Witten/Herdecke University, Witten, Germany.
- 700 1_
- $a Ziegler, Maren $u Wisplinghoff Laboratories, Cologne, Germany.
- 700 1_
- $a Vehreschild, J Janne $u Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany. Medical Faculty, Center for Integrated Oncology CIO Cologne/Bonn, University of Cologne, Cologne, Germany. German Centre for Infection Research (DZIF), partner site Bonn-Cologne, Cologne, Germany.
- 700 1_
- $a Liss, Blasius $u HELIOS Klinik Wuppertal Barmen, Wuppertal, Germany.
- 700 1_
- $a Hamprecht, Axel $u Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne, Germany.
- 700 1_
- $a Köhler, Philipp $u Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany. CECAD Cluster of Excellence, University of Cologne, Cologne, Germany.
- 700 1_
- $a Racil, Zdenek $u Department of Internal Medicine - Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Klimko, Nikolay $u Department of Clinical Mycology, Allergy and Immunology, North Western State Medical University, Saint Petersburg, Russia.
- 700 1_
- $a Sheppard, Donald C $u Division of Infectious Diseases, Departments of Medicine, Microbiology and Immunology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
- 700 1_
- $a Herbrecht, Raoul $u Department of Oncology and Hematology, Hôpitaux Universitaires de Strasbourg and Université de Strasbourg, Strasbourg, France.
- 700 1_
- $a Chowdhary, Anuradha $u Department of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.
- 700 1_
- $a Cornely, Oliver A $u Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany. CECAD Cluster of Excellence, University of Cologne, Cologne, Germany. Center for Clinical Trials, University Hospital of Cologne, Cologne, Germany.
- 700 1_
- $a FungiScope Group,
- 773 0_
- $w MED00010272 $t Mycoses $x 1439-0507 $g Roč. 60, č. 8 (2017), s. 508-516
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28730644 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180417152308 $b ABA008
- 999 __
- $a ok $b bmc $g 1287895 $s 1007222
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 60 $c 8 $d 508-516 $i 1439-0507 $m Mycoses $n Mycoses $x MED00010272
- LZP __
- $a Pubmed-20180404